The Role of Artificial Intelligence in Modern Allergology: A Review of Applications in Diagnosis, Prediction, and Management
Open Access
- 3 March 2026
- journal article
- review article
- Published by Wiley in JEADV Clinical Practice
Abstract
Artificial Intelligence is rapidly transforming allergology by enhancing diagnosis, risk prediction, automation, patient communication, education, and therapy development. Machine learning approaches, including convolutional neural networks, recurrent architectures, and transformer‐based models, enable analysis of complex datasets from genomics, imaging, clinical records, and patient‐reported outcomes. Artificial Intelligence applications in atopic disease diagnosis demonstrate high accuracy in imaging‐based detection, molecular phenotyping, and acoustic monitoring, while unsupervised learning methods such as Uniform Manifold Approximation and Projection and Hierarchical Density‐Based Spatial Clustering of Applications with Noise reveal distinct sensitisation clusters and patient risk profiles. Predictive modelling facilitates individualised management, including outcome prediction for oral food challenges, stratification of drug hypersensitivity risk, and forecasting disease progression in asthma and atopic dermatitis. Artificial Intelligence‐driven automation, such as skin prick test quantification and pollen monitoring, improves reproducibility and efficiency in clinical workflows. Additionally, Artificial Intelligence‐guided approaches are being explored in allergen immunotherapy development, including epitope mapping and hypoallergenic vaccine design, supported by experimental validation using assays such as enzyme‐linked immunosorbent assay and basophil activation tests. Large language models like ChatGPT show potential for patient engagement and education, though limitations in clinical reasoning and safety necessitate supervised use. Despite promising results, most Artificial Intelligence applications remain at early stages, with challenges including dataset size, generalisability, interpretability, cost, and integration into routine practice. Prospective validation, multicenter studies, and ethical oversight are essential for safe and effective implementation. Overall, Artificial Intelligence holds significant potential to advance allergology toward a predictive, personalised, and preventive model of care, offering new tools for precision diagnostics, risk assessment, and therapeutic innovation.Keywords
This publication has 30 references indexed in Scilit:
- ChatGPT Performance on 120 Interdisciplinary Allergology Questions—Systematic Evaluation With Clinical Error Impact Assessment for Critical Erroneous AI-Guided Chatbot AdviceThe Journal of Allergy and Clinical Immunology: In Practice, 2025
- Prediction of pediatric peanut oral food challenge outcomes using machine learningJournal of Allergy and Clinical Immunology: Global, 2024
- Revealing clinically relevant specific IgE sensitization patterns in Hymenoptera venom allergy with dimension reduction and clusteringWorld Allergy Organization Journal, 2023
- Alternaria spore exposure in Bavaria, Germany, measured using artificial intelligence algorithms in a network of BAA500 automatic pollen monitorsScience of The Total Environment, 2022
- Predictors of nonresponse to dupilumab in patients with atopic dermatitisAnnals of Allergy, Asthma & Immunology, 2022
- Automation of penicillin adverse drug reaction categorisation and risk stratification with machine learning natural language processingInternational Journal of Medical Informatics, 2021
- Machine Learning–Based Deep Phenotyping of Atopic DermatitisJAMA Dermatology, 2021
- Usefulness of an Artificial Neural Network in the Prediction of β-Lactam AllergyThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Development and Validation of a Penicillin Allergy Clinical Decision RuleJAMA Internal Medicine, 2020
- Highly accurate prediction of food challenge outcome using routinely available clinical dataJournal of Allergy and Clinical Immunology, 2011